Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.135 AUD -5.26% Market Closed
Market Cap: 39.4m AUD
Have any thoughts about
Next Science Ltd?
Write Note

Next Science Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Next Science Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Next Science Ltd
ASX:NXS
Gross Profit
$16.2m
CAGR 3-Years
77%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Nanosonics Ltd
ASX:NAN
Gross Profit
AU$132.4m
CAGR 3-Years
18%
CAGR 5-Years
16%
CAGR 10-Years
25%
Polynovo Ltd
ASX:PNV
Gross Profit
AU$99.2m
CAGR 3-Years
53%
CAGR 5-Years
52%
CAGR 10-Years
N/A
SDI Ltd
ASX:SDI
Gross Profit
AU$69m
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
6%
Anteris Technologies Ltd
ASX:AVR
Gross Profit
AU$5.4m
CAGR 3-Years
-7%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Ansell Ltd
ASX:ANN
Gross Profit
$624.8m
CAGR 3-Years
-8%
CAGR 5-Years
1%
CAGR 10-Years
0%
No Stocks Found

Next Science Ltd
Glance View

Market Cap
39.4m AUD
Industry
Health Care

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The firm's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

NXS Intrinsic Value
1.454 AUD
Undervaluation 91%
Intrinsic Value
Price

See Also

What is Next Science Ltd's Gross Profit?
Gross Profit
16.2m USD

Based on the financial report for Dec 31, 2023, Next Science Ltd's Gross Profit amounts to 16.2m USD.

What is Next Science Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
46%

Over the last year, the Gross Profit growth was 77%. The average annual Gross Profit growth rates for Next Science Ltd have been 77% over the past three years , 46% over the past five years .

Back to Top